JP2009516654A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009516654A5 JP2009516654A5 JP2008540237A JP2008540237A JP2009516654A5 JP 2009516654 A5 JP2009516654 A5 JP 2009516654A5 JP 2008540237 A JP2008540237 A JP 2008540237A JP 2008540237 A JP2008540237 A JP 2008540237A JP 2009516654 A5 JP2009516654 A5 JP 2009516654A5
- Authority
- JP
- Japan
- Prior art keywords
- angiogenic
- peptide fragment
- amino acid
- fragment according
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73547205P | 2005-11-10 | 2005-11-10 | |
| PCT/US2006/043921 WO2007059000A2 (en) | 2005-11-10 | 2006-11-13 | Modulation of angiogenesis by a-beta peptide fragments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009516654A JP2009516654A (ja) | 2009-04-23 |
| JP2009516654A5 true JP2009516654A5 (https=) | 2010-01-07 |
Family
ID=38049186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008540237A Withdrawn JP2009516654A (ja) | 2005-11-10 | 2006-11-13 | Ａ−ベータペプチドによる血管新生の調節 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8067372B2 (https=) |
| EP (1) | EP1951750A4 (https=) |
| JP (1) | JP2009516654A (https=) |
| KR (1) | KR20080095836A (https=) |
| CN (1) | CN101558080A (https=) |
| AU (1) | AU2006315686A1 (https=) |
| CA (1) | CA2619455A1 (https=) |
| WO (1) | WO2007059000A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080050367A1 (en) * | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| MY139983A (en) * | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
| MXPA05008156A (es) * | 2003-02-01 | 2005-09-30 | Neuralab Ltd | Inmunizacion activa para generar anticuerpos para beta-a soluble. |
| WO2006066089A1 (en) | 2004-12-15 | 2006-06-22 | Neuralab Limited | Humanized amyloid beta antibodies for use in improving cognition |
| US8067372B2 (en) | 2005-11-10 | 2011-11-29 | Alzheimer's Institute Of America, Inc. | Modulation of angiogenesis by A-beta peptide fragments |
| US8784810B2 (en) * | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
| US8003097B2 (en) * | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
| US20080292625A1 (en) * | 2007-04-18 | 2008-11-27 | Sally Schroeter | Prevention and treatment of cerebral amyloid angiopathy |
| PT2182983E (pt) | 2007-07-27 | 2014-09-01 | Janssen Alzheimer Immunotherap | Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados |
| EP2044951A1 (en) | 2007-10-02 | 2009-04-08 | Merz Pharma GmbH & Co. KGaA | The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| WO2009143489A2 (en) * | 2008-05-22 | 2009-11-26 | Archer Pharmaceuticals, Inc. | Modulation of angiogenesis by a-beta peptide fragments |
| US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
| US10882890B2 (en) * | 2014-07-25 | 2021-01-05 | Academia Sinica | Bipartite molecules and uses thereof in treating diseases associated with abnormal protein aggregates |
| US10772969B2 (en) | 2015-11-09 | 2020-09-15 | The University Of British Columbia | N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto |
| CA3004494A1 (en) * | 2015-11-09 | 2017-05-18 | The University Of British Columiba | Epitopes in amyloid beta mid-region and conformationally-selective antibodies thereto |
| US10759837B2 (en) | 2015-11-09 | 2020-09-01 | The University Of British Columbia | Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide |
| CN109476729A (zh) | 2016-07-18 | 2019-03-15 | 英属哥伦比亚大学 | 淀粉样蛋白β的抗体 |
| US20180125920A1 (en) | 2016-11-09 | 2018-05-10 | The University Of British Columbia | Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions |
| US12286469B2 (en) | 2017-07-18 | 2025-04-29 | The University Of British Columbia | Humanized antibodies binding to amyloid-beta (A-beta) |
| IT202100023357A1 (it) | 2021-09-09 | 2023-03-09 | Cheirontech S R L | Peptidi con attività anti-angiogenica |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105009A (en) * | 1959-10-30 | 1963-09-24 | Us Rubber Co | Anti-mitotic chemotherapeutic compounds |
| US5780587A (en) * | 1990-08-24 | 1998-07-14 | President And Fellows Of Harvard College | Compounds and methods for inhibiting β-protein filament formation and neurotoxicity |
| US5434050A (en) | 1991-08-13 | 1995-07-18 | Regents Of The University Of Minnesota | Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
| DE667959T1 (de) | 1992-10-26 | 2000-04-20 | Dale B Schenk | VERFAHREN UND ZUSAMMENSETZUNGEN FÜR DEN NACHWEIS VON LÖSLICHEM-g(b)-AMYLOIDPEPTID. |
| WO1994012627A1 (en) | 1992-11-25 | 1994-06-09 | Cephalon, Inc. | Transgenic animal model for alzheimer's disease |
| EP0815134B1 (en) * | 1995-03-14 | 2002-06-05 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
| WO1997021728A1 (en) | 1995-12-12 | 1997-06-19 | Karolinska Innovations Ab | PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
| US6043283A (en) * | 1996-09-20 | 2000-03-28 | Baylor College Of Medicine | Tyramine compounds and their neuronal effects |
| US5981471A (en) | 1997-02-06 | 1999-11-09 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
| NZ540564A (en) | 1999-11-29 | 2007-04-27 | Neurochem Int Ltd | Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases |
| US6998137B2 (en) | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| CA2467922A1 (en) * | 2001-08-10 | 2003-02-20 | Roskamp Research, Llc | Modulation of angiogenesis by a-beta peptides |
| GB0207362D0 (en) * | 2002-03-28 | 2002-05-08 | Univ Liverpool | Chemotherapy |
| US8067372B2 (en) | 2005-11-10 | 2011-11-29 | Alzheimer's Institute Of America, Inc. | Modulation of angiogenesis by A-beta peptide fragments |
-
2006
- 2006-11-13 US US11/598,299 patent/US8067372B2/en active Active
- 2006-11-13 WO PCT/US2006/043921 patent/WO2007059000A2/en not_active Ceased
- 2006-11-13 EP EP06837407A patent/EP1951750A4/en not_active Withdrawn
- 2006-11-13 JP JP2008540237A patent/JP2009516654A/ja not_active Withdrawn
- 2006-11-13 AU AU2006315686A patent/AU2006315686A1/en not_active Abandoned
- 2006-11-13 CA CA002619455A patent/CA2619455A1/en not_active Abandoned
- 2006-11-13 CN CNA2006800413012A patent/CN101558080A/zh active Pending
- 2006-11-13 KR KR1020087011171A patent/KR20080095836A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009516654A5 (https=) | ||
| HRP20201353T1 (hr) | Agonisti glukagonskog receptora | |
| IL262805B2 (en) | Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death | |
| JP2013543497A5 (https=) | ||
| EP3533461A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
| PE20231841A1 (es) | Coagonistas de los receptores glp-1 y gip adecuados para el suministro oral | |
| JP2017532343A5 (https=) | ||
| JP2015513527A5 (https=) | ||
| JP2013515057A5 (https=) | ||
| JP2018527288A5 (https=) | ||
| UA107571C2 (xx) | Фармацевтична композиція | |
| JP2016222689A5 (ja) | 合成ペプチド及び乾燥粉末薬剤輸送システム | |
| JP2019533722A5 (https=) | ||
| JP2006506942A5 (https=) | ||
| WO2006121656A3 (en) | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease | |
| NZ621196A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| FI3501534T3 (fi) | Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia | |
| JP2009521911A5 (https=) | ||
| JP2013533273A5 (https=) | ||
| JP2020507623A5 (https=) | ||
| WO2008033395A3 (en) | Melanocortin and transferrin fusion proteins | |
| HRP20171694T1 (hr) | Novi pripravci i postupci | |
| Kitamura et al. | Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders | |
| HK1223285A1 (zh) | 包含具有减小的免疫原性的经修饰的噬菌体g3p氨基酸序列的多肽 | |
| WO2010103515A3 (en) | Compositions and methods for prevention and treatment of neurodegenerative diseases |